Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel vs Vinorelbine in Elderly Advanced NSCLC
NCT00441922Phase 3Completed
- Sponsor
- Hellenic Oncology Research Group
- Start
- Jan 2003
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel, vinorelbine in non-small cell lung cancer (NSCLC), sponsored by Hellenic Oncology Research Group. Started Jan 2003; status: completed.
02
Drugs
docetaxelvinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00441922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00441922.